Estrogen signaling has an anti-tumorigenic role in the colonic mucosa, through selective activation of pro-apoptotic signaling mediated by ERβ, inhibition of inflammatory signals, and modulation of the tumor microenvironment and different immune surveillance mechanisms (Figure 1). The gene discussed is ESR2; the disease is neoplasm.